Intuitive Surgical, Inc. $ISRG Shares Acquired by Sarasin & Partners LLP

Sarasin & Partners LLP boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 128.2% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 244,426 shares of the medical equipment provider’s stock after acquiring an additional 137,302 shares during the period. Intuitive Surgical accounts for about 1.1% of Sarasin & Partners LLP’s portfolio, making the stock its 28th largest holding. Sarasin & Partners LLP’s holdings in Intuitive Surgical were worth $97,203,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. Newbridge Financial Services Group Inc. lifted its stake in shares of Intuitive Surgical by 300.0% in the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 33 shares during the last quarter. Laurel Wealth Advisors LLC purchased a new position in Intuitive Surgical during the fourth quarter worth about $31,000. Turning Point Benefit Group Inc. boosted its stake in Intuitive Surgical by 833.3% during the fourth quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock worth $32,000 after buying an additional 50 shares during the period. Motiv8 Investments LLC acquired a new stake in shares of Intuitive Surgical during the fourth quarter valued at about $34,000. Finally, Oakworth Capital Inc. raised its stake in shares of Intuitive Surgical by 281.2% in the 4th quarter. Oakworth Capital Inc. now owns 61 shares of the medical equipment provider’s stock valued at $35,000 after acquiring an additional 45 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $373.71 on Friday. The firm has a 50 day simple moving average of $393.78 and a 200-day simple moving average of $446.25. Intuitive Surgical, Inc. has a one year low of $328.57 and a one year high of $603.88. The firm has a market cap of $132.02 billion, a price-to-earnings ratio of 42.81, a PEG ratio of 2.71 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, topping the consensus estimate of $2.48 by $0.32. The firm had revenue of $2.89 billion for the quarter, compared to the consensus estimate of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The firm’s revenue for the quarter was up 18.4% on a year-over-year basis. During the same period in the prior year, the firm earned $1.81 EPS. Equities analysts predict that Intuitive Surgical, Inc. will post 8.87 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the stock. Robert W. Baird decreased their price objective on shares of Intuitive Surgical from $525.00 to $500.00 and set an “outperform” rating on the stock in a report on Friday, July 17th. BMO Capital Markets reiterated an “outperform” rating on shares of Intuitive Surgical in a report on Monday, July 20th. Royal Bank Of Canada cut their target price on Intuitive Surgical from $650.00 to $600.00 and set an “outperform” rating on the stock in a research report on Monday, July 13th. Stifel Nicolaus decreased their price target on Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating on the stock in a research note on Friday, July 17th. Finally, Deutsche Bank Aktiengesellschaft lowered their price target on Intuitive Surgical from $440.00 to $366.00 and set a “sell” rating for the company in a research report on Tuesday, June 2nd. Twenty research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $509.02.

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Iman Jeddi sold 5,625 shares of the stock in a transaction on Monday, June 1st. The stock was sold at an average price of $420.55, for a total value of $2,365,593.75. Following the sale, the senior vice president directly owned 6,463 shares in the company, valued at approximately $2,718,014.65. This trade represents a 46.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of Intuitive Surgical stock in a transaction on Wednesday, June 10th. The shares were sold at an average price of $424.14, for a total value of $169,656.00. Following the completion of the transaction, the executive vice president owned 5,720 shares of the company’s stock, valued at approximately $2,426,080.80. This trade represents a 6.54% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 6,634 shares of company stock valued at $2,796,795. Insiders own 0.60% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.